Kevin G Byrnes

Insider

First SEC filing: Feb. 14, 2019 · Latest: Feb. 14, 2019

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.

Insider at

MED selling Aug. 20, 2021

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 23 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

23 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Nov. 11, 2021	MED	M	5,000	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
Nov. 11, 2021	MED	M	5,000	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
Nov. 11, 2021	MED	M	2,917	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
Nov. 11, 2021	MED	F	6,149	$228.45	$1,404,739	14,922 Direct	-29.18%	Disposed	-94.9% (price as of 2026-08-21)
Nov. 11, 2021	MED	M	5,000	$27.68	$138,400	21,071 Direct	+31.11%	Acquired	-57.5% (price as of 2026-08-21)
Nov. 11, 2021	MED	M	5,000	$31.55	$157,750	16,071 Direct	+45.16%	Acquired	-62.7% (price as of 2026-08-21)
Nov. 11, 2021	MED	M	2,917	$26.52	$77,359	11,071 Direct	+35.77%	Acquired	-55.7% (price as of 2026-08-21)
Aug. 20, 2021	MED	S	673	$221.99	$149,399	8,154 Direct	-7.62%	Disposed	-94.7% (price as of 2026-08-21)
June 3, 2021	MED	A	650	—	—	8,827 Direct	+7.95%	Acquired	(price as of 2026-08-21)
Jan. 14, 2021	MED	G	2,000	—	—	8,177 Direct	-19.65%	Disposed	(price as of 2026-08-21)
June 16, 2020	MED	A	1,748	—	—	10,177 Direct	+20.74%	Acquired	(price as of 2026-08-21)
Feb. 22, 2019	MED	A	1,054	—	—	8,429 Direct	+14.29%	Acquired	(price as of 2026-08-21)
Feb. 7, 2018	MED	A	1,619	—	—	9,375 Direct	+20.87%	Acquired	(price as of 2026-08-21)
Feb. 16, 2017	MED	A	2,686	—	—	7,756 Direct	+52.98%	Acquired	(price as of 2026-08-21)
Feb. 4, 2016	MED	A	5,000	—	—	12,917 Direct	+63.16%	Acquired	(price as of 2026-08-21)
Feb. 4, 2016	MED	A	2,118	—	—	5,070 Direct	+71.75%	Acquired	(price as of 2026-08-21)
Feb. 17, 2015	MED	A	5,000	—	—	7,917 Direct	+171.41%	Acquired	(price as of 2026-08-21)
Feb. 17, 2015	MED	A	1,250	—	—	2,952 Direct	+73.44%	Acquired	(price as of 2026-08-21)
Feb. 5, 2014	MED	A	2,917	—	—	2,917 Direct	—	Acquired	(price as of 2026-08-21)
Feb. 5, 2014	MED	A	750	—	—	1,702 Direct	+78.78%	Acquired	(price as of 2026-08-21)
Dec. 31, 2013	MED	A	172	—	—	952 Direct	+22.05%	Acquired	(price as of 2026-08-21)
Sept. 30, 2013	MED	A	167	—	—	780 Direct	+27.24%	Acquired	(price as of 2026-08-21)
June 30, 2013	MED	A	175	—	—	613 Direct	+39.95%	Acquired	(price as of 2026-08-21)
May 23, 2013	MED	A	438	—	—	438 Direct	—	Acquired	(price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Nov. 11, 2021	MED	Stock Options	Common Stock (5,000)	$27.68	Feb. 4, 2026	5,000	Disposed
Nov. 11, 2021	MED	Stock Options	Common Stock (5,000)	$31.55	Feb. 17, 2025	5,000	Disposed
Nov. 11, 2021	MED	Stock Options	Common Stock (2,917)	$26.52	Feb. 5, 2024	2,917	Disposed
Feb. 4, 2016	MED	Stock Option	Common Stock (5,000)	$27.68	Feb. 4, 2026	5,000	Acquired
Feb. 17, 2015	MED	Stock Option	Common Stock (5,000)	$31.55	Feb. 17, 2025	5,000	Acquired
Feb. 5, 2014	MED	Stock Option	Common Stock (2,917)	$26.52	Feb. 5, 2024	2,917	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).